Trends in Pediatric Sickle Cell Disease-Related Mortality in the United States, 1983-2002

Journal of Pediatrics

Volumn 154, Issue 4, 2009, Pages 541-545

  Yanni, Emad ^a   Grosse, Scott D ^a   Yang, QuanHe ^a   Olney, Richard S ^a  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; DEATH; DEATH CERTIFICATE; FEMALE; HUMAN; INFANT; MALE; MORTALITY; NATIONAL HEALTH ORGANIZATION; NEWBORN; PEDIATRICS; PRIORITY JOURNAL; SICKLE CELL ANEMIA; UNITED STATES;

ADOLESCENT; AFRICAN AMERICANS; AGE DISTRIBUTION; ANEMIA, SICKLE CELL; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASES; FEMALE; HAEMOPHILUS VACCINES; HUMANS; INFANT; INFANT, NEWBORN; MALE; MASS IMMUNIZATION; MORTALITY; NEONATAL SCREENING; PNEUMOCOCCAL VACCINES; UNITED STATES;

EID: 62649144053     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2008.09.052     Document Type: Article

References (25)

1. Olney R.S. Preventing morbidity and mortality from sickle cell disease: a public health perspective. Am J Prev Med 16 (1999) 116-121
2. Olney R. Newborn screening for sickle cell disease. In: Khoury M., Burke W., and Thomson E. (Eds). Genetics and Public Health in the 21st Century (2000), Oxford University Press, New York 431-446
3. Centers for Disease Control and Prevention. Mortality among children with sickle cell disease identified by newborn screening during 1990-1994-California, Illinois, and New York. MMWR Morb Mortal Wkly Rep 47 (1998) 169-172
4. Davis H., Schoendorf K.C., Gergen P.J., and Moore Jr. R.M. National trends in the mortality of children with sickle cell disease, 1968 through 1992. Am J Public Health 87 (1997) 1317-1322
5. Quinn C.T., Rogers Z.R., and Buchanan G.R. Survival of children with sickle cell disease. Blood 103 (2004) 4023-4027
6. Bonds D.R. Three decades of innovation in the management of sickle cell disease: the road to understanding the sickle cell disease clinical phenotype. Blood Rev 19 (2005) 99-110
7. Yang Y.M. Comparison of costs to the health sector of comprehensive and episodic health care for sickle cell disease patients. Public Health Rep 110 (1995) 80-86
8. Centers for Disease Control. Update: Pneumococcal polysaccharide vaccine usage-United States. MMWR Morb Mortal Wkly Rep 33 (1984) 273-276 281
9. Gaston M.H., Verter J.I., Woods G., Pegelow C., Kelleher J., Presbury G., et al. Prophylaxis with oral penicillin in children with sickle cell anemia: a randomized trial. N Engl J Med 314 (1986) 1593-1599
10. Consensus conference: newborn screening for sickle cell disease and other hemoglobinopathies. JAMA 258 (1987) 1205-1209
11. Pass K.A., Lane P.A., Fernhoff P.M., Hinton C.F., Panny S.R., Parks J.S., et al. US newborn screening system guidelines II: follow-up of children, diagnosis, management, and evaluation. Statement of the Council of Regional Networks for Genetic Services (CORN). J Pediatr 137 (2000) S1-S46
12. Schoendorf K.C., Adams W.G., Kiely J.L., and Wenger J.D. National trends in Haemophilus influenzae meningitis mortality and hospitalization among children, 1980 through 1991. Pediatrics 93 (1994) 663-668
13. American Academy of Pediatrics. Red Book: Report of the Committee on Infectious Diseases. 26th edition (2003), American Academy of Pediatrics, Elk Grove Village, IL
14. Anderson R.N., Minino A.M., Hoyert D.L., and Rosenberg H.M. Comparability of cause of death between ICD-9 and ICD-10: preliminary estimates. Natl Vital Stat Rep 49 (2001) 1-32
15. Centers for Disease Control and Prevention. Update: newborn screening for sickle cell disease-California, Illinois, and New York, 1998. MMWR Morb Mortal Wkly Rep 49 (2000) 729-731
16. Frempong T. Newborn screening coupled with comprehensive follow-up reduced early mortality of sickle cell disease in Connecticut. Conn Med 71 (2007) 9-12
17. Halasa N.B., Shankar S.M., Talbot T.R., Arbogast P.G., Mitchel E.F., Wang W.C., et al. Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis 44 (2007) 1428-1433
18. Adamkiewicz T.V., Sarnaik S., Buchanan G.R., Iyer R.V., Miller S.T., Pegelow C.H., et al. Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination. J Pediatr 143 (2003) 438-444
19. American Academy of Pediatrics. Health supervision for children with sickle cell disease. Pediatrics 109 (2002) 526-535
20. Talbot T.R., Poehling K.A., Hartert T.V., Arbogast P.G., Halasa N.B., Mitchel E., et al. Elimination of racial differences in invasive pneumococcal disease in young children after introduction of the conjugate pneumococcal vaccine. Pediatr Infect Dis J 23 (2004) 726-731
21. Neuman H.B., and Wald E.R. Bacterial meningitis in childhood at the Children's Hospital of Pittsburgh, 1988-1998. Clin Pediatr (Phila) 40 (2001) 595-600
22. Shankar S.M., Arbogast P.G., Mitchel E., Cooper W.O., Wang W.C., and Griffin M.R. Medical care utilization and mortality in sickle cell disease: a population-based study. Am J Hematol 80 (2005) 262-270
23. Grosse SD, Schechter MS, Kulkarni R, Lloyd-Puryear MA, Strickland B, Trevathan E. Models of comprehensive, multidisciplinary care for individuals in the United States with genetic disorders. Pediatrics, in press.
24. Smith L.A., Oyeku S.O., Homer C., and Zuckerman B. Sickle cell disease: a question of equity and quality. Pediatrics 117 (2006) 1763-1770
25. Goss C.H., and Rosenfeld M. Update on cystic fibrosis epidemiology. Curr Opin Pulm Med 10 (2004) 510-514